KOSDAQ · Healthcare · ₩75B
₩2,365-1.46%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.3% · as of 26.10.27
Among 15 신약 개발 peers
Quarterly Revenue Growth
“새 매출원이 생겼지만 수익화는 더 지켜봐야 해요.”
In the company's words · 2026 2분기 filing